These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer. Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777 [TBL] [Abstract][Full Text] [Related]
3. Breast fine needle aspiration cytology. Utility as a screening tool for clinically palpable lesions. Costa MJ; Tadros T; Hilton G; Birdsong G Acta Cytol; 1993; 37(4):461-71. PubMed ID: 8328240 [TBL] [Abstract][Full Text] [Related]
4. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. Degnim AC; Visscher DW; Berman HK; Frost MH; Sellers TA; Vierkant RA; Maloney SD; Pankratz VS; de Groen PC; Lingle WL; Ghosh K; Penheiter L; Tlsty T; Melton LJ; Reynolds CA; Hartmann LC J Clin Oncol; 2007 Jul; 25(19):2671-7. PubMed ID: 17563394 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of topical nonsteroidal antiinflammatory drugs in mastalgia treatment. Colak T; Ipek T; Kanik A; Ogetman Z; Aydin S J Am Coll Surg; 2003 Apr; 196(4):525-30. PubMed ID: 12691925 [TBL] [Abstract][Full Text] [Related]
6. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions. Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687 [TBL] [Abstract][Full Text] [Related]
7. Breast cancer risk in women with radial scars in benign breast biopsies. Berg JC; Visscher DW; Vierkant RA; Pankratz VS; Maloney SD; Lewis JT; Frost MH; Ghosh K; Degnim AC; Brandt KR; Vachon CM; Reynolds CA; Hartmann LC Breast Cancer Res Treat; 2008 Mar; 108(2):167-74. PubMed ID: 18297395 [TBL] [Abstract][Full Text] [Related]
8. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887 [TBL] [Abstract][Full Text] [Related]
9. Spectrum of benign breast disorders in a university hospital. Khanna AK; Tapodar J; Misra MK J Indian Med Assoc; 1997 Jan; 95(1):5-8. PubMed ID: 9212559 [TBL] [Abstract][Full Text] [Related]
10. Mastalgia: a review of management. Olawaiye A; Withiam-Leitch M; Danakas G; Kahn K J Reprod Med; 2005 Dec; 50(12):933-9. PubMed ID: 16444894 [TBL] [Abstract][Full Text] [Related]
11. Pathologic features of breast cancers in women with previous benign breast disease. Jacobs TW; Byrne C; Colditz G; Connolly JL; Schnitt SJ Am J Clin Pathol; 2001 Mar; 115(3):362-9. PubMed ID: 11242792 [TBL] [Abstract][Full Text] [Related]
12. Value of scoring system in classification of proliferative breast disease on fine needle aspiration cytology. Mridha AR; Iyer VK; Kapila K; Verma K Indian J Pathol Microbiol; 2006 Jul; 49(3):334-40. PubMed ID: 17001879 [TBL] [Abstract][Full Text] [Related]
13. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study. Collins LC; Baer HJ; Tamimi RM; Connolly JL; Colditz GA; Schnitt SJ Cancer; 2007 Jan; 109(2):180-7. PubMed ID: 17154175 [TBL] [Abstract][Full Text] [Related]
14. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
15. Breast fluid cholesterol and cholesterol beta-epoxide concentrations in women with benign breast disease. Wrensch MR; Petrakis NL; Gruenke LD; Miike R; Ernster VL; King EB; Hauck WW; Craig JC; Goodson WH Cancer Res; 1989 Apr; 49(8):2168-74. PubMed ID: 2702658 [TBL] [Abstract][Full Text] [Related]
16. Four quadrant fine needle aspiration cytology for the detection of benign proliferative breast lesions accompanying breast carcinoma. Jayaram G; Gupta M; Lamba S Malays J Pathol; 1993 Dec; 15(2):137-42. PubMed ID: 8065175 [TBL] [Abstract][Full Text] [Related]
17. Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study. Cui Y; Page DL; Lane DS; Rohan TE Breast Cancer Res Treat; 2009 Mar; 114(1):113-20. PubMed ID: 18360772 [TBL] [Abstract][Full Text] [Related]
18. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. Rohan TE; Negassa A; Chlebowski RT; Habel L; McTiernan A; Ginsberg M; Wassertheil-Smoller S; Page DL J Natl Cancer Inst; 2008 Apr; 100(8):563-71. PubMed ID: 18398105 [TBL] [Abstract][Full Text] [Related]
19. Characterization by image cytometry of duct epithelial proliferative disease of the breast. King EB; Chew KL; Hom JD; Duarte LA; Mayall B; Miller TR; Neuhaus JM; Wrensch MR; Petrakis NL Mod Pathol; 1991 May; 4(3):291-6. PubMed ID: 1712475 [TBL] [Abstract][Full Text] [Related]
20. Benign breast lesions at risk of developing cancer--a challenging problem in breast cancer screening programs: five years' experience of the Breast Cancer Screening Program in Verona (1999-2004). Manfrin E; Mariotto R; Remo A; Reghellin D; Falsirollo F; Dalfior D; Bricolo P; Piazzola E; Bonetti F Cancer; 2009 Feb; 115(3):499-507. PubMed ID: 19117040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]